Cargando…

Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases

COVID-19 in patients with hematological diseases is associated with a high mortality. Moreover, preventive vaccination demonstrated reduced efficacy and the knowledge on influencing factors is limited. In this single-center study, antibody levels of the SARS-CoV-2 spike protein were measured ≥ 2 wee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rotterdam, Jil, Thiaucourt, Margot, Weiss, Christel, Schwaab, Juliana, Reiter, Andreas, Kreil, Sebastian, Steiner, Laurenz, Fenchel, Sebastian, Popp, Henning D., Hofmann, Wolf-Karsten, Bonatz, Karin, Gerhards, Catharina, Neumaier, Michael, Klein, Stefan A., Rao, Sonika, Jawhar, Mohamad, Saussele, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124009/ https://www.ncbi.nlm.nih.gov/pubmed/35597847 http://dx.doi.org/10.1007/s00277-022-04866-z

Ejemplares similares

Antibody Response to Vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid Neoplasms
por: Rotterdam, Jil, et al.
Publicado: (2021)

Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines
por: Gerhards, Catharina, et al.
Publicado: (2023)

Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort
por: Metzgeroth, Georgia, et al.
Publicado: (2023)

Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
por: Haselmann, Verena, et al.
Publicado: (2020)

Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
por: Kittel, Maximilian, et al.
Publicado: (2021)

Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection
por: Gerhards, Catharina, et al.
Publicado: (2021)

Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis
por: Naumann, Nicole, et al.
Publicado: (2021)

Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome
por: Gerhards, Catharina, et al.
Publicado: (2023)

Clinical evaluation of commercial automated SARS-CoV-2 immunoassays
por: Kittel, Maximilian, et al.
Publicado: (2021)

The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
por: Jawhar, Mohamad, et al.
Publicado: (2017)

Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosis
por: Riffel, Julia, et al.
Publicado: (2022)

Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection
por: Ast, Volker, et al.
Publicado: (2021)

Triptychon: Usability evaluation and implementation of a web-based application for patients’ lab and vital parameters
por: Kittel, Maximilian, et al.
Publicado: (2023)

Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis
por: Lübke, Johannes, et al.
Publicado: (2023)

Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosis
por: Lübke, Johannes, et al.
Publicado: (2019)

An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis
por: Riffel, Philipp, et al.
Publicado: (2020)

DNA Damage and DNA Damage Response in Chronic Myeloid Leukemia
por: Popp, Henning D., et al.
Publicado: (2020)

KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis
por: Jawhar, Mohamad, et al.
Publicado: (2019)

Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML
por: Christiani, Eva, et al.
Publicado: (2023)

Genotoxic Bystander Signals from Irradiated Human Mesenchymal Stromal Cells Mainly Localize in the 10–100 kDa Fraction of Conditioned Medium
por: Kohl, Vanessa, et al.
Publicado: (2021)

Protection against ultraviolet radiation by commercial summer clothing: need for standardised testing and labelling
por: Gambichler, Thilo, et al.
Publicado: (2001)

P1036: REAL-WORLD EFFICACY AND SAFETY OF MIDOSTAURIN-TREATMENT IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS
por: Lübke, Johannes, et al.
Publicado: (2023)

Proteins Marking the Sequence of Genotoxic Signaling from Irradiated Mesenchymal Stromal Cells to CD34+ Cells
por: Kohl, Vanessa, et al.
Publicado: (2021)

Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium
por: Altrock, Eva, et al.
Publicado: (2023)

Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies
por: Xu, Qingyu, et al.
Publicado: (2023)

Immunohistochemical investigations and introduction of new therapeutic strategies in scleromyxoedema: Case report
por: Breuckmann, Frank, et al.
Publicado: (2004)

Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer
por: Hofheinz, R-D, et al.
Publicado: (2004)

Separase activity distribution can be a marker of major molecular response and proliferation of CD34(+) cells in TKI-treated chronic myeloid leukemia patients
por: Spiess, Birgit, et al.
Publicado: (2020)

A new aberrantly spliced BCR‐ABL1 transcript variant (e13a1) identified in routine monitoring using different quantitative reverse transcription polymerase chain reaction techniques in a patient with chronic myeloid leukemia
por: Naumann, Nicole, et al.
Publicado: (2022)

Elogio de la locura/
por: Rotterdam, Erasmo de
Publicado: (1984)

Conservation of Non-Pest Whiteflies and Natural Enemies of the Cabbage Whitefly Aleyrodes proletella on Perennial Plants for Use in Non-Crop Habitats
por: Laurenz, Sebastian, et al.
Publicado: (2021)

Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes
por: Schmitt, Nanni, et al.
Publicado: (2021)

Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients
por: Gerhards, Catharina, et al.
Publicado: (2023)

Reverse Transcription Can Critically Impact the Diagnostic Outcome of BCR::ABL1 Quantitative Real-Time RT-PCR
por: Spiess, Birgit, et al.
Publicado: (2023)

Trading zones in a colony: Transcultural techniques at missionary stations in the Dutch East Indies, 1860 – 1940
por: Hård, Mikael, et al.
Publicado: (2020)

Setback zones can effectively reduce exposure to sea-level rise in Europe
por: Wolff, Claudia, et al.
Publicado: (2023)

Hematologic Manifestations in Celiac Disease—A Practical Review
por: Balaban, Daniel Vasile, et al.
Publicado: (2019)

Emerging trends in plasma‐free manufacturing of recombinant protein therapeutics expressed in mammalian cells
por: Grillberger, Leopold, et al.
Publicado: (2009)

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis
por: Nedoszytko, Boguslaw, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7jh66ijbe9h8j7qb41u601mjkt